{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:19:56Z","timestamp":1771607996076,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01996-4","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:05:13Z","timestamp":1762877113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The value of [18F]-FDG PET\/CT in the diagnostic of patients having gastrointestinal cancers with second primary malignancies: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beilei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"1996_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of Gastrointestinal cancer. Gastroenterology. 2020;159:335\u2013e34915.","journal-title":"Gastroenterology"},{"key":"1996_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41575-022-00726-3","volume":"20","author":"J Huang","year":"2023","unstructured":"Huang J, Lucero-Prisno DE, Zhang L, et al. Updated epidemiology of Gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol. 2023;20:271\u201387.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1996_CR3","doi-asserted-by":"publisher","first-page":"705999","DOI":"10.3389\/fimmu.2021.705999","volume":"12","author":"D-K Wang","year":"2021","unstructured":"Wang D-K, Zuo Q, He Q-Y, Li B. Targeted immunotherapies in Gastrointestinal cancer: from molecular mechanisms to implications. Front Immunol. 2021;12:705999.","journal-title":"Front Immunol"},{"key":"1996_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jcms.2022.06.001","volume":"50","author":"C Linz","year":"2022","unstructured":"Linz C, Brands RC, Hackenberg S, et al. [18F]FDG-PET\/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma \u2013 A retrospective study. J Cranio-Maxillofacial Surg. 2022;50:671\u20136.","journal-title":"J Cranio-Maxillofacial Surg"},{"key":"1996_CR5","doi-asserted-by":"publisher","first-page":"9841295","DOI":"10.1155\/2019\/9841295","volume":"2019","author":"HA Loomans-Kropp","year":"2019","unstructured":"Loomans-Kropp HA, Umar A. Increasing incidence of colorectal cancer in young adults. J Cancer Epidemiol. 2019;2019:9841295.","journal-title":"J Cancer Epidemiol"},{"key":"1996_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00384-022-04105-x","volume":"37","author":"D Robertson","year":"2022","unstructured":"Robertson D, Ng SK, Baade PD, Lam AK. Risk of extracolonic second primary cancers following a primary colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37:541\u201351.","journal-title":"Int J Colorectal Dis"},{"key":"1996_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1148\/radiol.2302021685","volume":"230","author":"H Agress","year":"2004","unstructured":"Agress H, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417\u201322.","journal-title":"Radiology"},{"issue":"3","key":"1996_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/med4.32","volume":"1","author":"BT Oggesen","year":"2023","unstructured":"Oggesen BT, Hamberg MLS, Rosenberg J. Practical management algorithms for late complications after colorectal and anal cancer\u2014basic treatment of late complications. Med Adv. 2023;1(3):260\u20139.","journal-title":"Med Adv"},{"key":"1996_CR9","first-page":"36","volume":"20","author":"L Pang","year":"2017","unstructured":"Pang L, Liu G, Shi H, Hu P, Li B, Cheng D. Nineteen cases with synchronous multiple primary cancers studied by 18F-FDG PET\/CT. Hell J Nucl Med. 2017;20:36\u201340.","journal-title":"Hell J Nucl Med"},{"key":"1996_CR10","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3390\/biomedicines12122708","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen H, Zhang Z, et al. Precision treatment of metachronous multiple primary malignancies based on constructing patient tumor-derived organoids. Biomedicines. 2024;12:2708.","journal-title":"Biomedicines"},{"key":"1996_CR11","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.ejrad.2015.09.013","volume":"84","author":"Z Huang","year":"2015","unstructured":"Huang Z, Xu X, Meng X, et al. Correlations between ADC values and molecular markers of ki-67 and HIF-1\u03b1 in hepatocellular carcinoma. Eur J Radiol. 2015;84:2464\u20139.","journal-title":"Eur J Radiol"},{"key":"1996_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/RCT.0000000000000978","volume":"44","author":"X Chen","year":"2020","unstructured":"Chen X, Chen X, Yang J, Li Y, Fan W, Yang Z. Combining dynamic contrast-enhanced magnetic resonance imaging and apparent diffusion coefficient maps for a radiomics nomogram to predict pathological complete response to neoadjuvant chemotherapy in breast cancer patients. J Comput Assist Tomogr. 2020;44:275\u201383.","journal-title":"J Comput Assist Tomogr"},{"key":"1996_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1996_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejrad.2017.05.036","volume":"93","author":"R Gallicchio","year":"2017","unstructured":"Gallicchio R, Nardelli A, Venetucci A, et al. F-18 FDG PET\/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer. Eur J Radiol. 2017;93:107\u201313.","journal-title":"Eur J Radiol"},{"key":"1996_CR15","doi-asserted-by":"publisher","first-page":"948","DOI":"10.4149\/neo_2022_220203N135","volume":"69","author":"M Ilcheva","year":"2022","unstructured":"Ilcheva M, Nikolova P, Hadzhiyska V, Mladenov K. Impact of FDG PET\/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers. Neoplasma. 2022;69:948\u201356.","journal-title":"Neoplasma"},{"key":"1996_CR16","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00405-011-1784-7","volume":"269","author":"N Kondo","year":"2012","unstructured":"Kondo N, Tsukuda M, Nishimura G. Diagnostic sensitivity of 18fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2012;269:1503\u20137.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1996_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s12149-013-0765-x","volume":"27","author":"A Hanamoto","year":"2013","unstructured":"Hanamoto A, Takenaka Y, Shimosegawa E, et al. Limitation of 2-deoxy-2-[F-18]fluoro-d-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer. Ann Nucl Med. 2013;27:880\u20135.","journal-title":"Ann Nucl Med"},{"key":"1996_CR18","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.3748\/wjg.v16.i31.3964","volume":"16","author":"L Sun","year":"2010","unstructured":"Sun L. Multiple primary malignant tumors of upper Gastrointestinal tract: A novel role of 18 F-FDG PET\/CT. World J Gastroenterol. 2010;16:3964.","journal-title":"World J Gastroenterol"},{"key":"1996_CR19","doi-asserted-by":"publisher","first-page":"e82812","DOI":"10.1371\/journal.pone.0082812","volume":"8","author":"S-H Chen","year":"2013","unstructured":"Chen S-H, Chan S-C, Chao Y-K, Yen T-C. Detection of synchronous cancers by Fluorodeoxyglucose positron emission tomography\/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan. PLoS ONE. 2013;8:e82812.","journal-title":"PLoS ONE"},{"issue":"12","key":"1996_CR20","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3390\/biomedicines12122708","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen H, Zhang Z, et al. Precision treatment of metachronous multiple primary malignancies based on constructing patient Tumor-Derived organoids. Biomedicines. 2024;12(12):2708.","journal-title":"Biomedicines"},{"key":"1996_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-5347(17)38649-4","volume":"142","author":"H Matzkin","year":"1989","unstructured":"Matzkin H, Braf Z. Multiple primary malignant neoplasms in the genitourinary tract: occurrence and etiology. J Urol. 1989;142:1\u201312.","journal-title":"J Urol"},{"key":"1996_CR22","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.18632\/aging.204250","volume":"14","author":"S Du","year":"2022","unstructured":"Du S, Li Y, Sun H, et al. The risk of developing second primary malignancies among colorectal cancer patients. Aging (milano). 2022;14:6756\u201379.","journal-title":"Aging (milano)"},{"key":"1996_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1046\/j.1442-2050.2000.00116.x","volume":"13","author":"S Nagasawa","year":"2000","unstructured":"Nagasawa S, Onda M, Sasajima K, Takubo K, Miyashita M. Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus: Official J Int Soc Dis Esophagus. 2000;13:226\u201330.","journal-title":"Dis Esophagus: Official J Int Soc Dis Esophagus"},{"key":"1996_CR24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1440-1746.1997.tb00536.x","volume":"12","author":"N Koide","year":"1997","unstructured":"Koide N, Yazawa K, Koike S, Adachi W, Amano J. Oesophageal cancer associated with other primary cancers: A study of 31 patients. J Gastroenterol Hepatol. 1997;12:690\u20134.","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"1996_CR25","first-page":"183","volume":"15","author":"K Yoshino","year":"1985","unstructured":"Yoshino K, Asanuma F, Hanatani Y, Otani Y, Kumai K, Ishibiki K. Multiple primary cancers in the stomach and another organ: frequency and the effects on prognosis. Jpn J Clin Oncol. 1985;15(Suppl 1):183\u201390.","journal-title":"Jpn J Clin Oncol"},{"key":"1996_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00423-004-0525-4","volume":"390","author":"YK Park","year":"2005","unstructured":"Park YK, Kim DY, Joo JK, et al. Clinicopathological features of gastric carcinoma patients with other primary carcinomas. Langenbecks Arch Surg. 2005;390:300\u20135.","journal-title":"Langenbecks Arch Surg"},{"key":"1996_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/0002-9343(94)90091-4","volume":"96","author":"P Watson","year":"1994","unstructured":"Watson P, Vasen HF, Mecklin JP, J\u00e4rvinen H, Lynch HT. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med. 1994;96:516\u201320.","journal-title":"Am J Med"},{"key":"1996_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.21037\/tlcr-20-513","volume":"9","author":"Z Hu","year":"2020","unstructured":"Hu Z, Zou X, Qin S, et al. Hormone receptor expression correlates with EGFR gene mutation in lung cancer in patients with simultaneous primary breast cancer. Translational Lung Cancer Res. 2020;9:325\u201336.","journal-title":"Translational Lung Cancer Res"},{"key":"1996_CR29","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.3390\/cancers15245788","volume":"15","author":"M Lu","year":"2023","unstructured":"Lu M, Zhang X, Chu Q, Chen Y, Zhang P. Susceptibility genes associated with multiple primary cancers. Cancers. 2023;15:5788.","journal-title":"Cancers"},{"key":"1996_CR30","doi-asserted-by":"publisher","first-page":"897451","DOI":"10.3389\/fonc.2022.897451","volume":"12","author":"Z Huimin","year":"2022","unstructured":"Huimin Z, Xueting W, Qi Q, et al. Multiple primary lung cancers with ALK rearrangement: A case report and literature review. Front Oncol. 2022;12:897451.","journal-title":"Front Oncol"},{"key":"1996_CR31","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/2211-5463.13491","volume":"12","author":"Y Kong","year":"2022","unstructured":"Kong Y, Li J, Lin H, Liang X, Zhou X. Landscapes of synchronous multiple primary cancers detected by next-generation sequencing. FEBS Open Bio. 2022;12:1996\u20132005.","journal-title":"FEBS Open Bio"},{"key":"1996_CR32","doi-asserted-by":"publisher","first-page":"110100","DOI":"10.1016\/j.clinimag.2024.110100","volume":"108","author":"J Zhang","year":"2024","unstructured":"Zhang J, Jin F, Li C, et al. Value of 18F-FDG PET\/CT in breast cancer with second primary malignancies. Clin Imaging. 2024;108:110100.","journal-title":"Clin Imaging"},{"key":"1996_CR33","first-page":"4277","volume":"31","author":"S Oka","year":"2011","unstructured":"Oka S, Uramoto H, Shimokawa H, Iwanami T, Tanaka F. The expression of ki-67, but not proliferating cell nuclear antigen, predicts poor disease free survival in patients with adenocarcinoma of the lung. Anticancer Res. 2011;31:4277\u201382.","journal-title":"Anticancer Res"},{"key":"1996_CR34","first-page":"3975","volume":"7","author":"M Dong","year":"2014","unstructured":"Dong M, Wei H, Hou J-M, et al. Possible prognostic significance of p53, Cyclin D1 and ki-67 in the second primary malignancy of patients with double primary malignancies. Int J Clin Exp Pathol. 2014;7:3975\u201383.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01996-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:05:14Z","timestamp":1762877114000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01996-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01996-4","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board (IRB) of Zhongshan Hospital (Xiamen), Fudan University (B2025-023) and written informed consent was waived by the IRB due to the retrospective nature of this study. The study was performed in accordance with the relevant guidelines and\/or regulations including the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Was waived by the IRB due to the retrospective nature of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"458"}}